Anti-atherogenic and anti-angiogenic activities of polyphenols from propolis

Journal of Nutritional Biochemistry

Volumn 23, Issue 6, 2012, Pages 557-566

  Daleprane, Julio Beltrame ^a   da Silva Freitas, Vanessa ^a   Pacheco, Alejandro ^b   Rudnicki, Martina ^a   Faine, Luciane Aparecida ^a   Dörr, Felipe Augusto ^a   Ikegaki, Masaharu ^c   Salazar, Luis Antonio ^b   Ong, Thomas Prates ^a   Abdalla, Dulcinéia Saes Parra ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSIDAD DE LA FRONTERA   (Chile)

^c FEDERAL UNIVERSITY OF ALFENAS   (Brazil)

Author keywords

Angiogenesis; Atherosclerosis; Dietary supplementation; Nutrigenomics; Polyphenols; Propolis

Indexed keywords

CD31 ANTIGEN; CD36 ANTIGEN; FIBROBLAST GROWTH FACTOR; GELATINASE B; LOW DENSITY LIPOPROTEIN RECEPTOR; MONOCYTE CHEMOTACTIC PROTEIN 1; PLATELET DERIVED GROWTH FACTOR; POLYPHENOL; PROPOLIS; TISSUE INHIBITOR OF METALLOPROTEINASE 1; VASCULAR CELL ADHESION MOLECULE 1; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIANGIOGENIC ACTIVITY; ANTIATHEROGENIC ACTIVITY; AORTA ROOT; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CONTROLLED STUDY; DOWN REGULATION; DRUG ACTIVITY; FEEDING; GENE EXPRESSION REGULATION; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; LIPID ANALYSIS; MOUSE; NONHUMAN; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION;

ANGIOGENESIS INHIBITORS; ANIMALS; AORTA; ATHEROSCLEROSIS; CHEMOKINE CCL2; CHOLESTEROL; DOWN-REGULATION; FIBROBLAST GROWTH FACTORS; INFLAMMATION; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PLANT EXTRACTS; PLATELET-DERIVED GROWTH FACTOR; POLYPHENOLS; PROPOLIS; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, LDL; TISSUE INHIBITOR OF METALLOPROTEINASE-1; UP-REGULATION; VASCULAR CELL ADHESION MOLECULE-1; VASCULAR ENDOTHELIAL GROWTH FACTORS;

ANIMALIA; MUS;

EID: 84860881700     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2011.02.012     Document Type: Article

References (60)

1. Mach F., Schönbeck U., Sukhova G.K., Atkinson E., Libby P. Reduction of atherosclerosis in mice by inhibition of CD40 signalling. Nature 1998, 394(6689):200-203.
2. Basu A., Penugonda K. Pomegranate juice: a heart-healthy fruit juice. Nutr Rev 2009, 67(1):49-56.
3. Lusis A.J. Atherosclerosis. Nature 2000, 407(6801):233-241.
4. Lindner J.R. Molecular imaging of cardiovascular disease with contrast-enhanced ultrasonography. Nat Rev Cardiol 2009, 6(7):475-481.
5. Slevin M., Kumar P., Gaffney J., Kumar S., Krupinski J. Can angiogenesis be exploited to improve stroke outcome? Mechanisms and therapeutic potential. Clin Sci 2006, 111:171-183.
6. Doyle B., Caplice N. Plaque neovascularization and antiangiogenic therapy for atherosclerosis. Am Coll Cardiol 2007, 49:2073-2080.
7. Herrmann J., Lerman L.O., Mukhopadhyay D., Napoli C., Lerman A. Angiogenesis in atherogenesis. Arterioscler Thromb Vasc Biol 2006, 26:1948-1957.
8. Fishbein M.C. The vulnerable and unstable atherosclerotic plaque. Cardiovasc Pathol 2010, 19(1):6-11.
9. Sforcin J.M. Propolis and the immune system: a review. J Ethnopharmacol 2007, 113(1):1-14.
10. Salatino A., Teixeira E.W., Negri G., Message D. Origin and chemical variation of Brazilian propolis. Evid Based Complement Alternat Med 2005, 2(1):33-38.
11. da Silva Filho A.A., de Sousa J.P., Soares S., Furtado N.A., Andrade e Silva M.L., Cunha W.R., et al. Antimicrobial activity of the extract and isolated compounds from Baccharis dracunculifolia D. C. (Asteraceae). Z Naturforsch C 2008, 63(1-2):40-46.
12. Libério S.A., Pereira A.L., Araújo M.J., Dutra R.P., Nascimento F.R., Monteiro-Neto V., et al. The potential use of propolis as a cariostatic agent and its actions on mutans group streptococci. J Ethnopharmacol 2009, 125(1):1-9.
13. Cuesta-Rubio O., Piccinelli A.L., Fernandez M.C., Hernández I.M., Rosado A., Rastrelli L. Chemical characterization of Cuban propolis by HPLC-PDA, HPLC-MS, and NMR: the brown, red, and yellow Cuban varieties of propolis. J Agric Food Chem 2007, 55(18):7502-7509.
14. Piccinelli A.L., Campone L., Dal Piaz F., Cuesta-Rubio O., Rastrelli L. Fragmentation pathways of polycyclic polyisoprenylated benzophenones and degradation profile of nemorosone by multiple-stage tandem mass spectrometry. J Am Soc Mass Spectrom 2009, 20(9):1688-1698.
15. Popolo A., Piccinelli L.A., Morello S., Cuesta-Rubio O., Sorrentino R., Rastrelli L., et al. Antiproliferative activity of brown Cuban propolis extract on human breast cancer cells. Nat Prod Commun 2009, 4(12):1711-1716.
16. Fonseca YM, Marquele-Oliveira F, Vicentini FT, Furtado NA, Sousa JP, Lucisano-Valim YM, Fonseca MJ. Evaluation of the potential of Brazilian propolis against UV-induced oxidative stress. Evid Based Complement Alternat Med. 2011; 2011.pii: 863917.
17. Simões-Ambrosio L.M., Gregório L.E., Sousa J.P., Figueiredo-Rinhel A.S., Azzolini A.E., Bastos J.K., et al. The role of seasonality on the inhibitory effect of Brazilian green propolis on the oxidative metabolism of neutrophils. Fitoterapia 2010, 81(8):1102-1108.
18. Vervelle A., Mouhyi J., Del Corso M., Hippolyte M.P., Sammartino G., Dohan Ehrenfest D.M. Mouthwash solutions with microencapsulated natural extracts: efficiency for dental plaque and gingivitis. Rev Stomatol Chir Maxillofac 2010, 111(3):148-151.
19. Parreira N.A., Magalhães L.G., Morais D.R., Caixeta S.C., de Sousa J.P., Bastos J.K., et al. Antiprotozoal, schistosomicidal, and antimicrobial activities of the essential oil from the leaves of Baccharis dracunculifolia. Chem Biodivers 2010, 7(4):993-1001.
20. Alencar S.M., Oldoni T.L., Castro M.L., Cabral I.S., Costa-Neto C.M., Cury J.A., et al. Chemical composition and biological activity of a new type of Brazilian propolis: red propolis. J Ethnopharmacol 2007, 113(2):278-283.
21. Jasprica I., Mornar A., Debeljak Z., Smolcić-Bubalo A., Medić-Sarić M., Mayer L., et al. In vivo study of propolis supplementation effects on antioxidative status and red blood cells. J Ethnopharmacol 2007, 110(3):548-554.
22. Hu F., Hepburn H.R., Li Y., Chen M., Radloff S.E., Daya S. Effects of ethanol and water extracts of propolis (bee glue) on acute inflammatory animal models. J Ethnopharmacol 2005, 100(3):276-283.
23. Rocha K.K., Souza G.A., Ebaid G.X., Seiva F.R., Cataneo A.C., Novelli E.L. Resveratrol toxicity: effects on risk factors for atherosclerosis and hepatic oxidative stress in standard and high-fat diets. Food Chem Toxicol 2009, 47(6):1362-1367.
24. Gerber M., Boutron-Ruault M.C., Hercberg S., Riboli E., Scalbert A., Siess M.H. Food and cancer: state of the art about the protective effect of fruits and vegetables. Bull Cancer 2002, (3):293-312.
25. Kumazawa S., Yoneda M., Shibata I., Kanaeda J., Hamasaka T., Nakayama T. Direct evidence for the plant origin of Brazilian propolis by the observation of honeybee behavior and phytochemical analysis. Chem Pharm Bull 2003, 51(6):740-742.
26. Daugsch A., Moraes C.S., Fort P., Park Y.K. Brazilian red propolis-chemical composition and botanical origin. Evid Based Complement Altern Med 2008, 5(4):435-441.
27. Ainsworth E.A., Gillespie K.M. Estimation of total phenolic content and other oxidation substrates in plant tissues using Folin-Ciocalteu reagent. Nat Protoc 2007, 2(4):875-877.
28. Pereira A.D., de Andrade S.F., de Oliveira Swerts M.S., Maistro E.L. First in vivo evaluation of the mutagenic effect of Brazilian green propolis by comet assay and micronucleus test. Food Chem Toxicol 2008, 46(7):2580-2584.
29. Moura A.C., Perazzo F.F., Maistro E.L. The mutagenic potential of Clusia alata (Clusiaceae) extract based on two short-term in vivo assays. Genet Mol Res 2008, 7(4):1360-1368.
30. Barros M.P., Lemos M., Maistro E.L., Leite M.F., Sousa J.P., Bastos J.K., et al. Evaluation of antiulcer activity of the main phenolic acids found in Brazilian green propolis. J Ethnopharmacol 2008, 120(3):372-377.
31. Büyükberber M., Savaş M.C., Baǧci C., Koruk M., Gülşen M.T., Tutar E., et al. The beneficial effect of propolis on cerulein-induced experimental acute pancreatitis in rats. Turk J Gastroenterol 2009, 20(2):122-128.
32. Reeves P.G., Nielsen F.H., Fahey G.C. AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition Ad Hoc Writing Committee on the reformulation of the AIN-76A rodent diet. J Nutr 1993, 123(11):1939-1951.
33. Dorfman S.E., Wang S., Vega-López S., Jauhiainen M., Lichtenstein A.H. Dietary fatty acids and cholesterol differentially modulate HDL cholesterol metabolism in Golden-Syrian hamsters. J Nutr 2005, 135(3):492-498.
34. Paigen B., Morrow A., Holmes P.A., Mitchell D., Williams R.A. Quantitative assessment of atherosclerotic lesions in mice. Atherosclerosis 1987, 68:231-240.
35. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta c (t)) method. Methods 2001, 25:402-408.
36. Nakanishi I., Uto Y., Ohkubo K., Miyazaki K., Yakumaru H., Urano S., et al. Efficient radical scavenging ability of artepillin C, a major component of Brazilian propolis, and the mechanism. Org Biomol Chem 2003, 1(9):1452-1454.
37. Nakajima Y., Tsuruma K., Shimazawa M., Mishima S., Hara H. Comparison of bee products based on assays of antioxidant capacities. BMC Complement Altern Med 2009, 9:4.
38. Russo A., Cardile V., Sanchez F., Troncoso N., Vanella A., Garbarino J.A. Chilean propolis: antioxidant activity and antiproliferative action in human tumor cell lines. Life Sci 2004, 76(5):545-558.
39. Munoz O., Pena R.C., Ureta E., Montenegro G., Timmermann B.N. Propolis from Chilean matorral hives. Z Naturforsch 2001, 56(3-4):269-272.
40. El-Sayed e.l.S.M., Abo-Salem O.M., Aly H.A., Mansour A.M. Potential antidiabetic and hypolipidemic effects of propolis extract in streptozotocin-induced diabetic rats. Pak J Pharm Sci 2009, 22(2):168-174.
41. Luo Q.F., Sun L., Si J.Y., Chen D.H. Hypocholesterolemic effect of stilbenes containing extract-fraction from Cajanus cajan L. on diet-induced hypercholesterolemia in mice. Phytomedicine 2008, 15:932-939.
42. Lee M.S., Kim C.T., Kim Y. Green tea (-)-epigallocatechin-3-gallate reduces body weight with regulation of multiple genes expression in adipose tissue of diet-induced obese mice. Ann Nutr Metab 2009, 54(2):151-157.
43. González-Santiago M., Martín-Bautista E., Carrero J.J., Fonollá J., Baró L., Bartolomé M.V., et al. One-month administration of hydroxytyrosol, a phenolic antioxidant present in olive oil, to hyperlipemic rabbits improves blood lipid profile, antioxidant status and reduces atherosclerosis development. Atherosclerosis 2006, 188(1):35-42.
44. Amarenco P., Labreuche J., Touboul P.J. High-density lipoprotein-cholesterol and risk of stroke and carotid atherosclerosis: a systematic review. Atherosclerosis 2008, 196(2):489-496.
45. Kramer M.K., Kriska A.M., Venditti E.M., Miller R.G., Brooks M.M., Burke L.E., et al. Translating the Diabetes Prevention Program: a comprehensive model for prevention training and program delivery. Am J Prev Med 2009, 37(6):505-511.
46. Koya-Miyata S., Arai N., Mizote A., Taniguchi Y., Ushio S., Iwaki K., et al. Propolis prevents diet-induced hyperlipidemia and mitigates weight gain in diet-induced obesity in mice. Biol Pharm Bull 2009, 32(12):2022-2028.
47. Nader M.A., el-Agamy D.S., Suddek G.M. Protective effects of propolis and thymoquinone on development of atherosclerosis in cholesterol-fed rabbits. Arch Pharm Res 2010, 33(4):637-643.
48. Ichi I., Hori H., Takashima Y., Adachi N., Kataoka R., Okihara K., et al. The beneficial effect of propolis on fat accumulation and lipid metabolism in rats fed a high-fat diet. J Food Sci 2009, 74(5):H127-H131.
49. Chung S., Timmins J.M., Duong M., Degirolamo C., Rong S., Sawyer J.K., et al. Targeted deletion of hepatocyte ABCA1 leads to very low density lipoprotein triglyceride overproduction and low density lipoprotein hypercatabolism. J Biol Chem 2010, 285(16):12197-12209.
50. Schreyer S.A., Vick C., Lystig T.C., Mystkowski P., LeBoeuf R.C. LDL receptor but not apolipoprotein E deficiency increases diet-induced obesity and diabetes in mice. Am J Physiol Endocrinol Metab 2002, 282(1):E207-E214.
51. Febbraio M., Podrez E.A., Smith J.D., Hajjar D.P., Hazen S.L., Hoff H.F., et al. Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice. J Clin Invest 2000, 105(8):1049-1056.
52. Li A.C., Brown K.K., Silvestre M.J., Willson T.M., Palinski W., Glass C.K. Peroxisome proliferator-activated receptor gamma ligands inhibit development of atherosclerosis in LDL receptor-deficient mice. J Clin Invest 2000, 106(4):523-531.
53. Packard R.R.S., Libby P. Inflammation in atherosclerosis: from vascular biology to biomarker discovery and risk prediction. Clin Chem 2008, 54:24-38.
54. Song J., Sumiyoshi S., Nakashima Y., Doi Y., Iida M., Kiyohara Y., et al. Overexpression of heme oxygenase-1 in coronary atherosclerosis of Japanese autopsies with diabetes mellitus: Hisayama study. Atherosclerosis. 2009, 202(2):573-581.
55. Cybulsky M.I., Iiyama K., Li H., Zhu S., Chen M., Iiyama M., et al. A major role for VCAM-1, but not ICAM-1, in early atherosclerosis. J Clin Invest 2001, 107(10):1255-1262.
56. Leonarduzzi G., Sevanian A., Sottero B., Arkan M.C., Biasi F., Chiarpotto E., et al. Up-regulation of the fibrogenic cytokine TGF-beta1 by oxysterols: a mechanistic link between cholesterol and atherosclerosis. FASEB J 2001, 15(9):1619-1621.
57. Sirol M., Moreno P.R., Purushothaman K.R., Vucic E., Amirbekian V., Weinmann H.J., et al. Increased neovascularization in advanced lipid-rich atherosclerotic lesions detected by gadofluorine-M-enhanced MRI: implications for plaque vulnerability. Circ Cardiovasc Imaging 2009, 2(5):391-396.
58. Inoue M., Itoh H., Ueda M., Naruko T., Kojima A., Komatsu R., et al. Vascular endothelial growth factor (VEGF) expression in human coronary atherosclerotic lesions: possible pathophysiological significance of VEGF in progression of atherosclerosis. Circulation 1998, 98(20):2108-2116.
59. Wågsäter D., Zhu C., Björck H.M., Eriksson P. Effects of PDGF-C and PDGF-D on monocyte migration and MMP-2 and MMP-9 expression. Atherosclerosis 2009, 202(2):415-423.
60. Chung A.W., Yang H.H., Sigrist M.K., Brin G., Chum E., Gourlay W.A., et al. Matrix metalloproteinase-2 and -9 exacerbate arterial stiffening and angiogenesis in diabetes and chronic kidney disease. Cardiovasc Res 2009, 84(3):494-504.